METLIFE (MET) Company Report

MetLife’s U.S. business comprises two core segments—Group Benefits and Retirement & Income Solutions—which collectively accounted for 60% of adjusted earnings.
Group Benefits, the largest U.S. player with $25 billion of premium (three times the next competitor), drives above-market growth through scale-driven capability investments ($2 billion over five years), broker consolidation tailwinds, and expanding low double-digit participation in voluntary products.
Retirement & Income Solutions leverages demographic tailwinds, writing $14 billion in Pension Risk Transfers last year and expanding into retail annuity reinsurance via Chariot Re (initial $11 billion of transactions), converting spread-based liabilities into fee-based income with third-party capital support.
MetLife is deploying AI-infused reengineering across underwriting, claims, and customer engagement to boost speed, accuracy, and top-line growth, and has built a Leave Management solution to serve state mandates for a population set to grow from 37 million today to 100 million by 2027.

7 days ago

Transcript

MetLife outlines US business growth strategies at Raymond James conference

MET

US Business (Group Benefits and Retirement & Income Solutions) drives 60% of adjusted earnings; Group Benefits wrote $25 billion of premium last year (3× the next competitor) and accounted for 25% of MetLife’s earnings.
Group Benefits growth is fueled by $2 billion in capability investments over the past five years, employer and broker consolidation, and low double-digit product participation—80% of sales come from existing customers with an average tenure over 20 years.
Leave Management addresses state-mandated leave complexity, scaling from 37 million covered Americans in 2019 to an expected 100 million by 2027; clients purchasing this service buy 4–5 additional MetLife products on average.
Retirement solutions leverage demographic tailwinds: completed $14 billion in Pension Risk Transfers from a $3 trillion DB universe, and expanded institutional annuity reinsurance via Chariot Re with $11 billion of transactions, converting spread income into fee-based revenue.

7 days ago

Transcript

MetLife outlines U.S. Group Benefits and Retirement Solutions growth strategies

MET

Guidance Update

MetLife’s U.S. Group Benefits and Retirement & Income Solutions businesses drive 60% of adjusted earnings, with Group Benefits generating $25 billion in premiums and 25% of MetLife’s earnings last year.
MetLife is the largest Group Benefits provider, 3× the size of its next competitor, having invested $2 billion over five years in digital, underwriting and distribution capabilities to sustain a 25% market share in national accounts and derive 80% of sales from existing customers with >20-year average tenure.
Key growth drivers in Group Benefits include employer demand to “do more with fewer,” ongoing broker/channel consolidation, and low-double-digit employee participation rates that MetLife is lifting via technology, data analytics and AI-driven guided advice during open enrollment.
In Retirement & Income Solutions, MetLife wrote $14 billion of Pension Risk Transfers last year as corporate plan sponsors de-risk, and is expanding institutional annuity reinsurance through Chariot Re—with $11 billion of seed transactions to access third-party capital and generate fee-based revenues.
MetLife has launched an AI-infused reengineering across claims, call centers, underwriting and customer engagement to improve speed, accuracy and top-line growth by closing the employee benefits “confusion gap”.

7 days ago

Transcript

MetLife issues $1 billion subordinated debentures due 2056

MET

Debt Issuance

$1.0 billion 5.850% Fixed-to-Fixed Reset Rate Subordinated Debentures due March 15, 2056 issued at 100.000% of par.
Settlement on February 26, 2026 (T+2) with $990 million net proceeds after 1.000% underwriting discount.
Interest resets on March 15, 2036 and every five years thereafter at the five-year Treasury rate + 1.817%, with semiannual payments and an optional deferral feature of up to five years per period.
Debt ranks subordinated unsecured, junior to senior indebtedness and pari passu with MetLife’s 6.350% fixed-to-fixed reset subordinated debentures due 2055.

Feb 26, 2026, 9:12 PM

8-K

MetLife outlines New Frontier strategy execution at BoA conference

MET

Guidance Update

M&A

MetLife’s New Frontier strategy delivered $10 billion in free cash flow for 2025 and shaved 40 bps off direct expenses, while maintaining targets of double-digit EPS growth, 15–17% ROE, and reducing the expense ratio to 11.3% by the end of the plan.
MetLife Investment Management closed the PineBridge acquisition on December 30, 2025, boosting AUM from $600 billion to over $740 billion and targeting $240–280 million in EBITDA synergies through expanded CLO, multi-asset and alternative capabilities.
In group benefits, early persistency actions led to strong 1-to-1 renewals, and leave & absence solutions now average 4–5 products bundled per sale, supporting growth within the 4–7% annual target range.
MetLife reported a record $14 billion in PRT transactions for 2025 with returns aligned to enterprise targets, achieved 17% growth in Japan’s third-sector market, and maintained LATAM momentum toward $1 billion in earnings.

Feb 10, 2026, 2:40 PM

Transcript

MetLife details 2025 strategy achievements and PineBridge acquisition

MET

M&A

Guidance Update

Under New Frontier, MetLife delivered 10% EPS growth, strong free cash flow and 40 bps reduction in its direct expense ratio in 2025.
Group Benefits growth was driven by leave and absence enhancements—with 4–5 products bundled per sale—and improved persistency, underpinning a 4–7% medium-term growth target.
MetLife Investment Management closed the PineBridge acquisition on December 30, 2025, boosting AUM from ~$600 bn to $740 bn+ and generating $22 bn of net flows.
Retirement solutions achieved 17% Third Sector growth in Japan and completed record $14 bn in PRT transactions, while leveraging reinsurance deals to support origination platforms.
International markets—including Mexico, Brazil, Japan and Korea—sustained mid-to-high single-digit growth via diversified, U.S. dollar-denominated products.

Feb 10, 2026, 2:40 PM

Transcript

MetLife outlines strategic progress and investment management update

MET

Guidance Update

M&A

MetLife’s New Frontier strategy delivered $10 billion in free cash flow and cut direct expenses by 40 bps in 2025, supporting efficiency and growth in group benefits, asset management, and international markets.
The company set a double-digit EPS growth target, underpinned by a 60/40 split between earnings growth and capital management, while shrinking its legacy retail runoff business.
MetLife reaffirmed its 15–17% ROE goal, driven by high-ROE new business returns and efficiency gains; it reduced its expense ratio to 11.7% in 2025 and targets 11.3% by year-end.
MetLife completed the PineBridge acquisition on Dec 30, raising AUM to $740 billion+ with $22 billion net inflows, and forecast $240–280 million of EBITDA growth in 2026 from revenue synergies.
In international markets, MetLife recorded 17% growth in Japan’s third sector, strong momentum in Mexico and Brazil despite VAT headwinds, and is on track toward a $1 billion earnings goal in Latin America.

Feb 10, 2026, 2:40 PM

Transcript

MetLife reports Q4 2025 results

MET

Earnings

Guidance Update

Share Buyback

Adjusted EPS of $2.58 ex-notable items in Q4 (up 24% y/y) on $1.6 billion of adjusted earnings; full-year 2025 adjusted EPS was $8.89 (+10% y/y) on $6.0 billion of adjusted earnings ex-notables.
Adjusted premiums, fees & other revenues (PFOs) rose 8% to $12.8 billion in Q4 (29% to $18.6 billion including PRT); segment Q4 adjusted earnings were Group Benefits $465 million (+12%), RIS $454 million (+18%), Asia $444 million (+1% cc), Latin America $227 million (+13%), EMEA $97 million (+64%).
Strong capital management with $3.6 billion of holding-company liquidity at year-end, retirement of $500 million debt, $430 million of share buybacks and $370 million of dividends in Q4, plus an additional $200 million repurchased in January.
2026 outlook targets: double-digit adjusted EPS growth, 15%–17% ROE, 65%–75% two-year average free cash flow ratio, 12.1% direct expense ratio and $1.6 billion of pre-tax variable investment income.

Feb 5, 2026, 2:00 PM

Transcript

MetLife reports Q4 2025 results and outlines 2026 guidance

MET

Earnings

Guidance Update

Adjusted EPS of $2.49 and $2.58 ex-notables, up 24% YoY, with $1.6 billion in adjusted earnings in Q4 2025.
Full-year 2025 adjusted EPS of $8.89, up ~10%, with 16% adjusted ROE and 11.7% direct expense ratio—both ahead of targets.
PFOs rose 8% to $12.8 billion in Q4 (29% including retained PRT), driven by robust volume growth across businesses.
Q4 segment adjusted earnings: Group Benefits $465 million, Retirement & Income Solutions $454 million, Asia $444 million, Latin America $227 million, EMEA $97 million, and MetLife Investment Management $60 million.
2026 guidance includes double-digit adjusted EPS growth, 15%–17% ROE, a 65%–75% free cash flow ratio, ~12.1% direct expense ratio, and ~$1.6 billion pre-tax variable investment income.

Feb 5, 2026, 2:00 PM

Transcript

MetLife reports Q4 2025 results

MET

Earnings

MetLife delivered 10% adjusted EPS growth and achieved an adjusted ROE of 16.0% in FY25, surpassing targets, with FY25 adjusted EPS of $8.83 per share.
Q4 2025 adjusted earnings excluding notable items rose 18% YoY to $1,709 million ( $2.58 per share), driven by underwriting and investment margin expansion across core segments.
FY25 free cash flow ratio reached 81%, above the 65–75% target; direct expense ratio improved to 11.7%, beating the 12.1% goal.
Q4 variable investment income was $393 million (pre-tax), including $497 million from private equity, contributing to $1.187 billion VII for FY25 (post-tax).
Segment adjusted earnings ex-notable items in Q4: Group Benefits +12% to $465 million; Retirement & Income Solutions +18% to $454 million; EMEA +64% to $97 million; MetLife Investment Management +275% to $60 million.

Feb 5, 2026, 2:00 PM

Presentation

Fintool News

In-depth analysis and coverage of METLIFE.

Corporate

MetLife CEO Declares 'Right Strategy at the Right Time' as PineBridge Boosts AUM to $742B

Feb 10

View all news

Earnings Transcripts

Quarterly earnings call transcripts for METLIFE.

Q4 2025

Feb 5, 2026

→

Q3 2025

Nov 6, 2025

→

Q2 2025

Aug 7, 2025

→

View All Transcripts

Ask Fintool AI Agent

Get instant answers from SEC filings, earnings calls & more

What did Michel A. Khalaf say about margins?What are METLIFE's strategic priorities?How is METLIFE positioned vs competitors?How did METLIFE do last quarter?

METLIFE (MET)

Analyst Earnings Quarterly Reports

Q3 2025

Q2 2025

Q1 2025

Q4 2024

Q4 2025

Executives

Michel A. Khalaf

Adrienne O'Neill

Bill Pappas

Eric Clurfain

John D. McCallion

Lyndon Oliver

Marlene Debel

Michael Roberts

Monica Curtis

Nuria Garcia

Ramy Tadros

Shurawl Sibblies

Board Members

Carla A. Harris

Carlos M. Gutierrez

Christian Mumenthaler

Denise M. Morrison

Diana L. McKenzie

Jeh C. Johnson

Laura J. Hay

Mark A. Weinberger

R. Glenn Hubbard

William E. Kennard

Analyst Coverage

Suneet Kamath

Wesley Carmichael

Joel Hurwitz

Ryan Krueger

Thomas Gallagher

Alex Scott

Jimmy Bhullar

Elyse Greenspan

Jamminder Bhullar

Cave Montazeri

Tom Gallagher

Wilma Burdis

Wilma Jackson Burdis

John Barnidge

Nick Anido

Latest news

Fintool News

MetLife CEO Declares 'Right Strategy at the Right Time' as PineBridge Boosts AUM to $742B

Earnings Transcripts

Q4 2025

Q3 2025

Q2 2025

Ask Fintool AI Agent